Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MT1CP is a member of the metallothionein gene family and is annotated as a pseudogene, meaning it is a DNA sequence similar to functional metallothionein genes but is not itself believed to encode a functional protein[1]. Metallothionein family members, in general, are small, cysteine-rich proteins involved in metal homeostasis (such as zinc and copper), detoxification of heavy metals, protection against oxidative stress, and regulation of cell proliferation and apoptosis[2][3][4]. MT1CP, due to its pseudogene status, is not currently understood to play an active biochemical role and is not a direct therapeutic target or biomarker. Functional genes in this family can be induced by heavy metals and are studied in contexts such as cancer, cellular stress, and toxicology, but MT1CP itself lacks evidence for protein product or drug interaction[1]. Pseudogenes are generally considered non-coding and not druggable or direct clinical targets. However, some pseudogenes may be transcribed and influence gene regulation by acting as competing endogenous RNAs or via other mechanisms; there is no established evidence that MT1CP engages in such functions[1]. The metallothionein protein family is relevant to metal metabolism, redox biology, and various diseases, but MT1CP has no proven direct role[2][3][4]. If the query intended to reference a protein-coding member (such as “Metallothionein 1C”), review the actual locus or symbol, as “MT1C” is a protein-coding gene, whereas “MT1CP” is the pseudogene. MT1CP is a pseudogene related to the metallothionein family, does not produce a functional protein, is not a therapeutic target, and has no established roles in disease, drug interaction, or as a biomarker[1]. For metallothionein-related protein functions, see other family members such as MT1, MT2, etc.[2][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metallothionein 1C, pseudogene (MT1CP).